Friday, December 20, 2013

Well, time for another update. This one is not so positive. Despite her “numbers” looking better, Nyshie herself isn’t getting better. She's using more oxygen, her appetite hasn’t improved, she's continuing to get weaker etc. We consulted with three doctors and the conclusion is that while this protocol was probably having an impact it simply wasn’t having enough of an impact to make her well. When we started this we knew that it had never been used with someone so sick and close to death. We are thankful that it has given her a few more months but it has become clear that it is not going to be the “miracle” we had hoped for. Yesterday, Nyshie decided that it was time to stop treatment and let this journey take its own course. The Hospice Nurse Practitioner was out this morning and said that the cancer has moved deeper into her lymphatic system as she is showing some areas of swelling and pain. She assured Nyshie that they will be able to control whatever pain develops, which, of course is everyone’s biggest concern. She has endured so much and fought so hard but she is ready to end this phase of the battle and let go. She feels very much at peace with her decision and we are all supportive. We fully expect she will be here for Christmas next week and maybe even New Years, as she is alert, eating some, awake most of the day and still quite connected to the world. She may even be rooting for the Broncos in the Super Bowl in January. Of course, we thank all of you for your unbelievable love and support through this seven year journey and hope your holidays are filled with love, joy, and caring. Paul & Nyshie

Monday, November 11, 2013

Time for an update ..

The roller coaster of course continues, but not quite as chaotic. Her weight dropped to a low of 85 pounds which frightened us. MD in Boulder thought that maybe her Pancreas had stopped producing enough digestive enzymes so she wrote an Rx. Within a few days she went to 89lbs and today 88lbs. We are very hopeful that this will be the key. We upped her Magnesium, which has been chronically low, and also leads to weight loss. In a week or so we should know much more. We will also get labs done within the next couple of weeks which will give us some objective data. If these numbers are improving we will know we are on the right track. Her appetite is improving as well as her ability to eat a bit more. Woke up yesterday wanting some venison summer sausage. Go figure. My brother John to the rescue so we are anxiously awaiting the UPS truck. Her energy is better most days but still occasionally sinks and just doesn't feel “right.” Has no pain from the cancer but still needs significant pain meds to deal with the lung tubes. Hopefully these will eventually come out.

So I continue to be hopeful. She certainly is better than a month ago even though we still encounter bumps along the way.

Paul

Thursday, October 31, 2013

news from Paul ....

Well, three days now without any major setbacks. For a moment, at least, the roller coaster is running fairly smoothly. Increasing energy and appetite. Still very weak and she cannot tolerate much volume of food but some things are sounding good to her. This morning she got up, dressed, and we went for a ride through the Garden of the Gods. Didn't miss the chance to have a McDonald's sausage biscuit and hash browns. She was able to handle a few bites of each. We were gone for about an hour. This is the first time she has wanted to go anywhere in at least six weeks. Pretty amazing. Of course, as she goes so do I, so my mood and energy are up as well. We are going to start walking more to build strength. Even if it's just around the patio a couple of times. Nice to have some good news. Whatever everyone is doing, just keep doing it.


Paul

Friday, October 25, 2013

FYI ... info on the alternative treatment protocol.

Pursuing No Evidence of Disease (NED)

Non-toxic combination therapy targeting key cancer pathways.

While significant progress has been made in treating early stage cancer, over 50 percent of major solid tumors are diagnosed after invasion or metastasis has occurred. Only one-half of these patients are alive after 5 years. In the last seven years, new cancer drugs have provided limited incremental survival benefits (averaging only 3.2 months) and at a prohibitive cost. NED therapy represents a novel approach with the potential to significantly increase survival and quality of life for cancer patients.

Cancer results from deregulation of eight key or “hallmark” cellular pathways, of which four are the most therapeutically relevant for advanced disease.* Long-term survival of metastatic solid tumor patients will require the development of a well-tolerated combination of compounds that act together to halt or reverse aberrant signaling in all four of these pathways.

Existing cancer drug discovery and development is challenged by the genetic complexity, redundancy and instability of cancer, coupled with the lack of efficient procedures for development and approval of more than one compound at a time in the form of a combination therapy. Innovators must find a combination that simultaneously reverses aberrant signaling in all four key pathways and does this without significant toxicity.

NED Biosystems has identified a proprietary combination of orally available small molecules with excellent safety profiles and established ability to reverse aberrant signaling in each of these four key cancer pathways. The NED combination agents individually inhibit one or more pathways such that each pathway is hit by at least three separate molecules. This combination affords significant potential for therapeutic synergy in each pathway. The NED approach is the first to consider and identify a compound combination based on both existing clinical safety profiles and the ability to target the four most therapeutically relevant cancer pathways involved in advanced cancer.

Rebecca Lambert, Founder and Executive Chairman NED Biosystems, Inc. 


*The four are angiogenesis, apoptosis, cellular metabolism and energetics, and immune surveillance.